Genomic testing: which women can do it and why it is useful

On the sidelines of the national conference ‘Next perspectives. From the constellation of regional health systems to a new scenario of application of genomic tests in Italy’, Alessandra Fabi, national councilor of the Italian Association of Medical Oncology (Aiom), explains how genomic tests are able to identify, with greater precision, women who can really benefit from chemotherapy and those for whom the benefits are absent. Aggressive and disabling treatments and a whole significant series of side effects and direct and indirect costs can be avoided and limited.

Subjects